Cargando…
Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country
Since smoking accounts for around 30% of all cancer deaths, public health campaigns often focus on smoking cessation as a means of primary prevention. However, smoking after cancer diagnosis is also associated with a higher symptom burden and lower survival rate. As data regarding smoking cessation...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395437/ https://www.ncbi.nlm.nih.gov/pubmed/34449569 http://dx.doi.org/10.3390/clinpract11030067 |
_version_ | 1783744172204752896 |
---|---|
author | Golčić, Marin Tomaš, Ilijan Stevanović, Aleksandra Golčić, Goran Dobrila-Dintinjana, Renata Erić, Suzana Šambić-Penc, Mirela Baretić Marinac, Martina Gović-Golčić, Lidija Majnarić, Tea |
author_facet | Golčić, Marin Tomaš, Ilijan Stevanović, Aleksandra Golčić, Goran Dobrila-Dintinjana, Renata Erić, Suzana Šambić-Penc, Mirela Baretić Marinac, Martina Gović-Golčić, Lidija Majnarić, Tea |
author_sort | Golčić, Marin |
collection | PubMed |
description | Since smoking accounts for around 30% of all cancer deaths, public health campaigns often focus on smoking cessation as a means of primary prevention. However, smoking after cancer diagnosis is also associated with a higher symptom burden and lower survival rate. As data regarding smoking cessation vary dramatically between different populations, we aimed to analyze smoking prevalence in cancer patients, smoking cessation after cancer diagnosis, and the factors associated with smoking cessation in the setting of a developing country. We performed a cross-sectional survey on 695 patients in two clinical hospital centers. After cancer diagnosis, 15.6% of cancer patients stopped smoking. Male gender, younger age, and smoking-related cancer were the main factors associated with greater smoking cessation (p < 0.05). A total of 96% of breast cancer patients continued to smoke after cancer diagnosis and, compared to lung and colorectal cancer patients, exhibited a lower reduction in the number of cigarettes smoked (p = 0.023). An alarming rate of smoking prevalence was recorded in younger patients (45.6% at the time of cancer diagnosis) suggesting a future rise in smoking-related cancers and complications. These results should guide anti-smoking public health campaigns in transitional countries with a critical focus on younger and breast cancer patients. |
format | Online Article Text |
id | pubmed-8395437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83954372021-08-28 Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country Golčić, Marin Tomaš, Ilijan Stevanović, Aleksandra Golčić, Goran Dobrila-Dintinjana, Renata Erić, Suzana Šambić-Penc, Mirela Baretić Marinac, Martina Gović-Golčić, Lidija Majnarić, Tea Clin Pract Article Since smoking accounts for around 30% of all cancer deaths, public health campaigns often focus on smoking cessation as a means of primary prevention. However, smoking after cancer diagnosis is also associated with a higher symptom burden and lower survival rate. As data regarding smoking cessation vary dramatically between different populations, we aimed to analyze smoking prevalence in cancer patients, smoking cessation after cancer diagnosis, and the factors associated with smoking cessation in the setting of a developing country. We performed a cross-sectional survey on 695 patients in two clinical hospital centers. After cancer diagnosis, 15.6% of cancer patients stopped smoking. Male gender, younger age, and smoking-related cancer were the main factors associated with greater smoking cessation (p < 0.05). A total of 96% of breast cancer patients continued to smoke after cancer diagnosis and, compared to lung and colorectal cancer patients, exhibited a lower reduction in the number of cigarettes smoked (p = 0.023). An alarming rate of smoking prevalence was recorded in younger patients (45.6% at the time of cancer diagnosis) suggesting a future rise in smoking-related cancers and complications. These results should guide anti-smoking public health campaigns in transitional countries with a critical focus on younger and breast cancer patients. MDPI 2021-08-10 /pmc/articles/PMC8395437/ /pubmed/34449569 http://dx.doi.org/10.3390/clinpract11030067 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Golčić, Marin Tomaš, Ilijan Stevanović, Aleksandra Golčić, Goran Dobrila-Dintinjana, Renata Erić, Suzana Šambić-Penc, Mirela Baretić Marinac, Martina Gović-Golčić, Lidija Majnarić, Tea Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country |
title | Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country |
title_full | Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country |
title_fullStr | Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country |
title_full_unstemmed | Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country |
title_short | Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country |
title_sort | smoking cessation after a cancer diagnosis: a cross-sectional analysis in the setting of a developing country |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395437/ https://www.ncbi.nlm.nih.gov/pubmed/34449569 http://dx.doi.org/10.3390/clinpract11030067 |
work_keys_str_mv | AT golcicmarin smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT tomasilijan smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT stevanovicaleksandra smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT golcicgoran smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT dobriladintinjanarenata smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT ericsuzana smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT sambicpencmirela smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT bareticmarinacmartina smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT govicgolciclidija smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry AT majnarictea smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry |